Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Cancer Research|May 2, 2013
Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signalingChristian D Young, Adam D Pfefferle, Philip Owens, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapiesAriella B Hanker, Adam D Pfefferle, Justin M Balko, et al.
Cell Death & Disease|January 19, 2018
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancersMichelle M Williams, Linus Lee, Thomas Werfel, et al.
Cancer Research|November 11, 2018
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1Thomas A Werfel, David L Elion, Bushra Rahman, et al.
The Journal of Clinical Investigation|September 25, 2014
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involutionJamie C Stanford, Christian Young, Donna Hicks, et al.
Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Breast Cancer Research : BCR|July 19, 2022
Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancerAnn Hanna, Mellissa J Nixon, M Valeria Estrada, et al.
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
The Journal of Clinical Investigation|April 10, 2014
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCKatherine R Amato, Shan Wang, Andrew K Hastings, et al.
Biomaterials|April 9, 2023
Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencingShrusti S Patel, Ella N Hoogenboezem, Fang Yu, et al.
Pageof 8